Company was originally incorporated as Private Limited, under the Companies Act, 1956 (“Companies Act”) in the name and style of “M/s Infinium Pharmachem Private Limited” on November 21st, 2003. Later on August 12th, 2022, company was converted into public limited company, the name of the Company was changed to “Infinium Pharmachem Limited”. The Company was incorporated with the objective of manufacturing and supplying of various pharma related chemicals, bulk drugs, pharma intermediates etc. currently provides the widest range of Iodine derivatives in the market, with more than 250+ intermediates and 15+ APIs. The Company has a good quantity of competent raw material suppliers, which allows it to bypass many supply chain bottlenecks. Professional and experience team including in-house R&D and Quality Assurance departments.